Alaunos Therapeutics Inc. has announced the appointment of Michael A. Jerman as a new director, effective immediately. Jerman fills the vacancy left by Dale Curtis Hogue's resignation and will also serve as the chair of the Audit Committee and a member of the Compensation Committee, replacing Holger Weis, who has recently been appointed Chief Executive Officer of the company.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Alaunos Therapeutics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000950170-25-096656), on July 17, 2025, and is solely responsible for the information contained therein.